Avantor Inc., a provider of mission-critical products and services to customers in the life sciences and advanced technology industries, has expanded its partnership with the National Institute for Bioprocessing Research and Training (NIBRT) to focus on addressing urgent bottlenecks in biopharma manufacturing, particularly in downstream optimization for monoclonal antibodies (mAbs), by providing cutting-edge equipment and specialized training.
 
Avantor will provide a full suite of aseptic fluid handling equipment, including Masterflex pump systems and supporting single-use systems. These advanced tools are designed to create realistic biopharmaceutical workflows in NIBRT’s training rooms, offering trainees the opportunity to gain hands-on experience with equipment that mirrors real-world industry settings.
 
“Monoclonal antibodies have revolutionized medicine by providing personalized treatments for chronic and debilitating conditions, but as researchers continue to advance their potential, manufacturers face increasing pressure to get new therapies to market quickly and safely,” said Benoit Gourdier, EVP and Head of Avantor’s Bioscience Production Segment. “The ability to handle large-scale fluid volumes while maintaining quality in a closed system, is a key area that can be optimized to avoid delays and product loss. By combining our expertise with the latest technology, we are equipping industry partners with the tools and knowledge they need to maximize productivity and streamline their processes.”
 
In addition, Avantor’s team of bioprocessing experts is developing and delivering targeted training sessions to tackle pressing scale-up challenges. These expert-led trainings will focus on optimizing downstream processes for mAbs production, utilizing the full capabilities of the donated Masterflex aseptic fluid transfer systems to enhance efficiency and scalability.
 
“At NIBRT, we are committed to providing world-class training and expertise to support the biopharma sector in overcoming key manufacturing challenges,” said Kate Cotter, Director of training delivery at NIBRT. “This enhanced partnership with Avantor allows us to further equip the industry with the tools and knowledge necessary to drive innovation and improve efficiency in critical areas, such as downstream processing for monoclonal antibodies. By combining advanced equipment with our specialized training programs, we enable our trainees to meet current and future skills demands with confidence.”
 
Avantor and NIBRT’s partnership advances the biopharmaceutical industry through research, training, and innovation. By providing NIBRT with advanced technology and expertise, Avantor aims to shape bioprocessing’s future and foster new therapies.